Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
BMC Cancer
|
June 28, 2018
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Danielle C Glassman, Randze L Palmaira, Christina M Covington, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 15, 2025
Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm
Sam Y Son, Sara Velayati, Ken Zhao, et al.
Investigational New Drugs
|
August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor
James J Harding, Todd M Bauer, Daniel S W Tan, et al.
Cancer Research Communications
|
April 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Benjamin Garmezy, Mitesh J Borad, Rastilav Bahleda, et al.
Frontiers in Immunology
|
May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors
James J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
International Journal of Molecular Sciences
|
December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
Perla Chami, Youssef Diab, Danny N Khalil, et al.
Current Oncology (Toronto, Ont.)
|
May 24, 2024
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization
Ken Zhao, Sam Son, Anita Karimi, et al.
The Journal of Applied Laboratory Medicine
|
December 19, 2022
Standard Venipuncture vs a Capillary Blood Collection Device for the Prospective Determination of Abnormal Liver Chemistry
Enaksha Wickremsinhe, Antoniu Fantana, Erwin Berthier, et al.
Cancer Medicine
|
August 26, 2020
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
Imane El Dika, Marinela Capanu, Joanne F Chou, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
BMC Cancer
|
June 28, 2018
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Danielle C Glassman, Randze L Palmaira, Christina M Covington, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 15, 2025
Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm
Sam Y Son, Sara Velayati, Ken Zhao, et al.
Investigational New Drugs
|
August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor
James J Harding, Todd M Bauer, Daniel S W Tan, et al.
Cancer Research Communications
|
April 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Benjamin Garmezy, Mitesh J Borad, Rastilav Bahleda, et al.
Frontiers in Immunology
|
May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors
James J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
International Journal of Molecular Sciences
|
December 9, 2023
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
Perla Chami, Youssef Diab, Danny N Khalil, et al.
Current Oncology (Toronto, Ont.)
|
May 24, 2024
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization
Ken Zhao, Sam Son, Anita Karimi, et al.
The Journal of Applied Laboratory Medicine
|
December 19, 2022
Standard Venipuncture vs a Capillary Blood Collection Device for the Prospective Determination of Abnormal Liver Chemistry
Enaksha Wickremsinhe, Antoniu Fantana, Erwin Berthier, et al.
Cancer Medicine
|
August 26, 2020
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
Imane El Dika, Marinela Capanu, Joanne F Chou, et al.
Page
of 14